Oncology Regional Medical Scientific Director (RMSD) - Genitourinary (GU) Cancers - New York City (Remote)

Job Description

Our Medical Affairs team advances patient care by engaging in scientific exchange with external medical experts and industry professionals ensuring the scientific value of our products is realized. We engage and train internal employees to ensure that they thoroughly comprehend the science behind the medicine and review further unmet medical needs to bolster collaboration and further differentiate our portfolio.   

We are seeking a Growth and Improvement minded Oncology Regional Medical Scientific Director that can help drive our Strategic Operating Priorities.

• Invent | Pursue the Most Promising Internal and External Science to Address Significant Unmet Medical Needs

• Execute | Prioritize Resources Behind Our Key Growth Drivers (Oncology, Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base Business)

• Adapt | Develop Our People, Culture and Business Model to Evolve with a Dynamic Landscape

• Diverse Talent | We are committed to providing an inclusive and welcoming environment with supporting leadership behaviors because having a high-performing, engaged workforce is critical to our ability to deliver innovative solutions to patients and customers around the world

• Values and Standards | Our Steadfast Commitment to Our Values and Standards will Continue to Guide Us as We Take on New Challenges and Will Always be Fundamental to Our Success – They are a Competitive Advantage for Us

Location: This position primarily covers the New York City territory. Candidates must reside in the territory.

Strategic Summary

• The Oncology Regional Medical Scientific Director is a credentialed (i.e., PhD, PharmD, DNP, MD) oncology expert who engages in bidirectional exchange of scientific or medical information with Scientific Leaders (SLs). The role provides balanced, factual, scientific information about non-product areas of interest to the company and replies to scientific questions from SLs, including questions about company products | The work of a Regional Medical Scientific Director is aligned to: Scientific Exchange, Research, Scientific Congress Support, and Scientific Insights

• Regional Medical Scientific Director's liaise between the scientific community and the company to enhance the comprehension of scientific foundations and goals for approved, in-development, and active company-sponsored trials and/or investigator-sponsored research studies | The Regional Medical Scientific Director serves as a role model for other field medical team members in ways that include on-boarding and/or sharing of therapeutic expertise)

Key Responsibilities

Scientific Exchange

• Develops professional relationships and engages with national and regional SLs to ensure access to medical and scientific information on areas of Genitourinary (GU) Cancers and company products.

• Conducts peer-to-peer scientific discussions and maintains a reliable presence with those SLs to ensure they have a medical contact within the company

• Addresses scientific questions and directs SL inquiries on issues outside of Regional Medical Scientific Director scope (e.g., grants) to appropriate company resources consistent with applicable policies

• Maintains current knowledge and comprehension of dynamic scientific and clinical environment in the Company's Areas of Interest (AOI)

Research

• Upon request from Global Center for Scientific Affairs (GCSA).

• Initiates discussions with SLs and/or potential investigators that include scientific/data exchange within our AOI to determine the alignment with our research strategies, studies concepts, scientific merit, and qualifications for a specific compound or trial.

• Enhances the comprehension of the scientific foundations and goals of investigator-sponsored research.

• Identifies barriers to patient enrollment and retention efforts to achieve study milestones.

• Upon request from Global Clinical Trial Operations (GCTO).

• Recommends study sites and identifies potential investigators to participate in phase II-IV clinical development programs, conducts Site Initiation Visits (SIVs), and detects barriers to patient enrollment and retention efforts